Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Franke

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Case Reports in Oncology|July 17, 2024
Sustained Clinical Response to Ivosidenib in Previously Treated Patients with Advanced Intrahepatic Cholangiocarcinoma Harboring an IDH1 R132 Mutation: Two Case ReportsChristian Müller, Sabine Franke, Timo Reisländer, et al.
Pathology, Research and Practice|December 3, 2014
Characterization of cathepsin X in colorectal cancer development and progressionDoerthe Jechorek, Julia Votapek, Frank Meyer, et al.
Diagnostics (Basel, Switzerland)|June 13, 2025
Non-Coding RNAs in Diagnostic Pathology of High-Grade Central OsteosarcomaAlbert Roessner, Sabine Franke, Julian Schreier, et al.
Digestion|September 5, 2018
The BRAF Status May Predict Response to Sorafenib in Gastrointestinal Stromal Tumors Resistant to Imatinib, Sunitinib, and Regorafenib: Case Series and Review of the LiteratureCaspar Franck, Rosa Rosania, Sabine Franke, et al.
Pathology, Research and Practice|October 24, 2022
Genetics and epigenetics in conventional chondrosarcoma with focus on non-coding RNAsAlbert Roessner, Sabine Franke, Julian Schreier, et al.
Pathology, Research and Practice|December 1, 2014
Dysregulation of apoptotic signaling pathways by interaction of RPLP0 and cathepsin X/Z in gastric cancerAnne Teller, Doerthe Jechorek, Roland Hartig, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 22, 2023
Factors Affecting Performance of DNA Methylation as a Potential Biomarker in Ascites for Peritonitis and Peritoneal CarcinomatosisKatrin Bose, Florian G Scurt, Cosima Thon, et al.
Contemporary Oncology (Poznan, Poland)|January 30, 2020
<i>MLH1</i> promoter hypermethylation in uterine carcinosarcoma rarely coexists with <i>TP53</i> mutationMichal Kunc, Anna Gabrych, Bartlomiej Rekawiecki, et al.
The American Journal of Pathology|November 5, 2002
Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphomaSabine Franke, Iwona Wlodarska, Brigitte Maes, et al.
Pathology, Research and Practice|March 24, 2023
Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcomaFranziska S Karras, Julian Schreier, Kerstin Körber-Ferl, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Case Reports in Oncology|July 17, 2024
Sustained Clinical Response to Ivosidenib in Previously Treated Patients with Advanced Intrahepatic Cholangiocarcinoma Harboring an IDH1 R132 Mutation: Two Case ReportsChristian Müller, Sabine Franke, Timo Reisländer, et al.
Pathology, Research and Practice|December 3, 2014
Characterization of cathepsin X in colorectal cancer development and progressionDoerthe Jechorek, Julia Votapek, Frank Meyer, et al.
Diagnostics (Basel, Switzerland)|June 13, 2025
Non-Coding RNAs in Diagnostic Pathology of High-Grade Central OsteosarcomaAlbert Roessner, Sabine Franke, Julian Schreier, et al.
Digestion|September 5, 2018
The BRAF Status May Predict Response to Sorafenib in Gastrointestinal Stromal Tumors Resistant to Imatinib, Sunitinib, and Regorafenib: Case Series and Review of the LiteratureCaspar Franck, Rosa Rosania, Sabine Franke, et al.
Pathology, Research and Practice|October 24, 2022
Genetics and epigenetics in conventional chondrosarcoma with focus on non-coding RNAsAlbert Roessner, Sabine Franke, Julian Schreier, et al.
Pathology, Research and Practice|December 1, 2014
Dysregulation of apoptotic signaling pathways by interaction of RPLP0 and cathepsin X/Z in gastric cancerAnne Teller, Doerthe Jechorek, Roland Hartig, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 22, 2023
Factors Affecting Performance of DNA Methylation as a Potential Biomarker in Ascites for Peritonitis and Peritoneal CarcinomatosisKatrin Bose, Florian G Scurt, Cosima Thon, et al.
Contemporary Oncology (Poznan, Poland)|January 30, 2020
<i>MLH1</i> promoter hypermethylation in uterine carcinosarcoma rarely coexists with <i>TP53</i> mutationMichal Kunc, Anna Gabrych, Bartlomiej Rekawiecki, et al.
The American Journal of Pathology|November 5, 2002
Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphomaSabine Franke, Iwona Wlodarska, Brigitte Maes, et al.
Pathology, Research and Practice|March 24, 2023
Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcomaFranziska S Karras, Julian Schreier, Kerstin Körber-Ferl, et al.
Pageof 3